Seabridge Gold, Inc. Ordinary Shares (Canada) (SA): Price and Financial Metrics


Seabridge Gold, Inc. Ordinary Shares (Canada) (SA): $16.52

-0.52 (-3.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SA to Watchlist
Sign Up

Industry: Miners - Gold


Ranked

of 46

in industry

SA Stock Price Chart Interactive Chart >

Price chart for SA

SA Price/Volume Stats

Current price $16.52 52-week high $22.86
Prev. close $17.04 52-week low $5.25
Day low $16.17 Volume 464,600
Day high $17.21 Avg. volume 418,019
50-day MA $19.62 Dividend yield N/A
200-day MA $18.61 Market Cap 1.23B

Seabridge Gold, Inc. Ordinary Shares (Canada) (SA) Company Bio


Seabridge Gold Inc. engages in the acquisition and exploration of gold properties located in North America. It also explores for copper, silver, and molybdenum ores. The company was formerly known as Seabridge Resources Inc. and changed its name to Seabridge Gold Inc. in June 2002. The company was founded in 1979 and is based in Toronto, Canada.


SA Latest News Stream


Event/Time News Detail
Loading, please wait...

SA Latest Social Stream


Loading social stream, please wait...

View Full SA Social Stream

Latest SA News From Around the Web

Below are the latest news stories about Seabridge Gold Inc that investors may wish to consider to help them evaluate SA as an investment opportunity.

Seabridge Gold: Invitation to Red Cloud's 2021 Pre-PDAC Mining Showcase

Toronto, Ontario--(Newsfile Corp. - March 3, 2021) - Seabridge Gold (TSX: SEA) is pleased to announce that the Company will be presenting at Red Cloud’s 2021 Pre-PDAC Mining Showcase. We invite our shareholders and all interested parties to join us there. The annual conference will be a virtual event this year and will take place from March 3-5, 2021. Rudi Fronk, Chairman & CEO will be presenting on ...

Yahoo | March 3, 2021

Cellectis, Cytovia In $760M Partnership To Develop Natural Killer Cells; Stock Pops 9%

Cytovia Therapeutics and Cellectis, a clinical stage cell therapy company announced a $760 million research and development collaboration to develop TALEN gene edited iPSC NK and CAR NK cells. Shares of Cellectis jumped more than 9% in Tuesday's pre-market trading session. The partnership includes development, regulatory and sales milestone payments of up to $760 million from Cytovia to Cellectis (CLLS) for the first 5 products. Cellectis is also entitled to royalty payments in single digits on net sales of all partnered products that Cytovia will commercialize.

Kailas Salunkhe on TipRanks | February 16, 2021

How Many Seabridge Gold Inc. (TSE:SEA) Shares Do Institutions Own?

Every investor in Seabridge Gold Inc. ( TSE:SEA ) should be aware of the most powerful shareholder groups. Insiders...

Yahoo | February 9, 2021

Seabridge Gold Team Member Announced as National Award Winner from Woman in Mining Canada

Toronto, Ontario--(Newsfile Corp. - February 8, 2021) - Seabridge Gold's (TSX:SEA) (NYSE:SA) Taryn Cutler has won the 2021 Indigenous Student Trailblazer Award by Woman in Mining Canada. The Indigenous Student Trailblazer Award is awarded to young Indigenous women in post-secondary studies, college, vocational training and university who are successfully integrating into the minerals and metals industry. The women considered for this award are establishing a path in mining and inspiring other young indigenous women ...

Yahoo | February 8, 2021

These 3 Stocks Will Double -- If Wall Street Has Its Way

Investors are always looking for stocks that will perform well in the future. Unfortunately, Wall Street analysts don't have a perfect track record of projecting what's going to happen to the stocks they cover. Let's look more closely at three stocks that Wall Street says will double and see if we agree.

Yahoo | February 3, 2021

Read More 'SA' Stories Here

SA Price Returns

1-mo -14.00%
3-mo -8.12%
6-mo -11.52%
1-year 47.76%
3-year 51.56%
5-year 46.71%
YTD -21.59%
2020 52.46%
2019 4.46%
2018 17.08%
2017 38.65%
2016 -1.69%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0521 seconds.